LSX World Congress, London
We are attending the LSX World Congress for Senior executives from the pharmaceuticals, biotech, and venture industries in London between the 5-6th February 2019. Come meet us!
Biotech Showcase 2019/JP Morgan Week, San Francisco
AIM Targeted Therapies presented at the Biotech Showcase 2019 in San Francisco on the 8th of January. Our CEO Dr Glenn Abrahmsohn was also interviewed by Proactive Investors
Have some fun... See our launch video!
AIM Targeted Therapies is based in Key Biscayne, Florida. We work in two areas: pain relief; and infection control with healing. Our products provide revolutionary methods of modulating the physiological pathways of the body to produce predictable outcomes in the above therapeutic areas. All our IP is either patented or has patents pending in a number of countries.